In this region, North America Drug Delivery Market is projected to reach USD 823.55 billion by 2024 from USD 501.37 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024.
Based on geography, the North America drug delivery market is segmented into 3 geographical regions, such as,

U.S.,
Mexico,
Canada,

North America drug delivery market competition by top players including -
Johnson & Johnson Services, Inc., is going to dominate the North America drug delivery market followed by Novartis AG along with others such as
F. Hoffmann-La Roche AG,
Pfizer, Inc.,
GlaxoSmithKline plc. ,
Merck & Co., Sanofi,
Antares Pharma,
3M,
Becton Dickinson and Company,
Nemera, Cima Labs, Inc.,
Dali Medical Devices,
Alkermes, Foamis,
Ypsomed,
Skyepharma AG,
Valeant Pharmaceuticals
DSM Biomedical

Catalent, Inc.
The drug delivery market is segmented on the basis of route of administration, end users, and region.
On the basis of route of administration the market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal.

Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills.
The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups. The Injectable drug delivery segment is further segmented into devices and formulations.
The devices segment is categorized as conventional injections, self-injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices.
The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes.
The injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable.

The pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers.
The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
Ocular drug delivery is segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays.

Nasal drug delivery is segmented into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal.
The transdermal topical drug delivery includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices.

The transmucosal drug delivery segment is sub segmented into oral transmucosal and others.
The oral transmucosal segment includes products such as buccal and sublingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
On the basis of distribution channel the North America drug delivery market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.

On the basis of end users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others.